Variables | |
---|---|
Age (mean ± SD, years) | 60.6 ± 8.8 |
Gender (%) | Â |
 Male | 76.1 (n = 54) |
 Female | 23.9 (n = 17) |
BMI (mean ± SD, kg/m2) | 25.8 ± 8.8 |
Smokers (%) | Â |
 Current smokers | 14.1 (n = 10) |
 Former smokers | 56.3 (n = 40) |
 Non smokers | 29.6 (n = 21) |
Type of thoracic cancer (%) | Â |
 Adenocarcinoma | 42.3 (n = 30) |
 Squamous cell carcinoma | 16.9 (n = 12) |
 Small cell carcinoma | 5.6 (n = 4) |
 Mesothelioma (MPM) | 23.9 (n = 17) |
 Others | 11.3 (n = 8) |
Lung cancer TNM stage (%) excluding MPM | Â |
 stage IB | 1.9 (n = 1) |
 stage IIA | 5.6 (n = 3) |
 stage IIB | 3.7 (n = 2) |
 stage IIIA | 16.7 (n = 9) |
 stage IIIB | 11.1 (n = 6) |
 stage IV | 61.1 (n = 33) |
VSRQ total score (mean ± SD) | 46.3 ± 17 |
HAD scale | Â |
 Anxiety score (median + IQR) | 7 [5–10] |
 Depression score (median + IQR) | 6 [3–10] |